ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.9, sa.3, ss.223-230, 2009 (SCI-Expanded, Scopus, TRDizin)
Objective: Levosimendan (LS) is a new inodilator agent that improves cardiac contractility by increasing the sensitivity of troponin C to calcium, which usage in cardiac surgery has been growing in the recent years. We aimed to determine the best timing of the administration of LS in high-risk patients who underwent cardiovascular surgery.